Edward Clark Keystone
Edward Clark Keystone publishes mostly in Rheumatology, Hematology and Immunology, on topics such as Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research and Spondyloarthritis Studies and Treatments.
- World rank
- #151,734 of 7,710,434 ranked researchers
- Rank in Canada
- #5,006 of 183,316
- Works
- 569
- Citations
- 38k
- Citations per work
- 66.5
What does Edward Clark Keystone research?
Edward Clark Keystone's work is mostly in Medicine (67%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences37966.6%
- Medicine37966.6%
- Everything else13924.5%
- Life Sciences518.9%
- 1Rheumatology42% of their works
- 2Hematology11% of their works
- 3Immunology9% of their works
- 4Genetics6% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Autoimmune and Inflammatory Disorders Research
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Chronic Lymphocytic Leukemia Research
- Biosimilars and Bioanalytical Methods
- Lymphoma Diagnosis and Treatment
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Edward Clark Keystone's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Hemophagocytic Lymphohistiocytosis, Juvenile Idiopathic Arthritis, Rituximab, Ankylosing Spondylitis and Spondyloarthritis.
- Fc Receptors
- Classification
- Biosimilars
- Chronic Lymphocytic Leukemia
- Antiphospholipid Syndrome
- Spondyloarthritis
- Rituximab
- Hemophagocytic Lymphohistiocytosis
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Juvenile Idiopathic Arthritis
- Ankylosing Spondylitis
- Monoclonal Antibodies
- Systemic Lupus Erythematosus
- Genomic Aberrations
- Immunogenicity
- Lymphoma
- Therapeutic Antibodies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Autoantibodies5012 topics
- Inflammation4121 topic
- Rheumatoid Arthritis4121 topic
- Hemophagocytic Lymphohistiocytosis1521 topic
- Juvenile Idiopathic Arthritis1521 topic
- Rituximab1392 topics
- Ankylosing Spondylitis1341 topic
- Spondyloarthritis1341 topic
- Monoclonal Antibodies1152 topics
- Antiphospholipid Syndrome891 topic
- Systemic Lupus Erythematosus891 topic
- Chronic Lymphocytic Leukemia781 topic
- Genomic Aberrations781 topic
- Biosimilars661 topic
- Immunogenicity661 topic
- Classification611 topic
- Lymphoma611 topic
- Fc Receptors491 topic
- Therapeutic Antibodies491 topic
Where does Edward Clark Keystone work?
Edward Clark Keystone's main affiliation in the publication record is University of Toronto, Canada.
How many publications and citations does Edward Clark Keystone have?
OpenAlex counts 569 works and 37,833 citations for Edward Clark Keystone, an h-index of 85, ranking #151,734 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Edward Clark Keystone. Posts are plain text and can be reported.